Premier Path Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
4,297
-1,810
-30% -$159K 0.04% 322
2026
Q1
$552K Sell
6,107
-2,628
-30% -$241K 0.07% 251
2025
Q4
$785K Sell
8,735
-3,323
-28% -$315K 0.1% 196
2025
Q3
$1.19M Sell
12,058
-1,108
-8% -$110K 0.15% 149
2025
Q2
$1.2M Buy
13,166
+694
+6% +$67.1K 0.17% 147
2025
Q1
$1.41M Buy
12,472
+2,168
+21% +$232K 0.22% 109
2024
Q4
$1.09M Sell
10,304
-947
-8% -$102K 0.17% 147
2024
Q3
$1.21M Buy
11,251
+217
+2% +$23.7K 0.19% 138
2024
Q2
$1.2M Buy
11,034
+724
+7% +$85.3K 0.2% 123
2024
Q1
$1.36M Buy
10,310
+1,372
+15% +$171K 0.26% 98
2023
Q4
$1.09M Buy
+8,938
New +$997K 0.24% 104

Other funds holding ZBH

Premier Path Wealth Partners's ZBH Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its Zimmer Biomet (ZBH) stake by 30% in Q2 2026, selling an estimated $159K and leaving 4,297 shares worth $370K. The position accounts for 0.04% of the portfolio, ranked #322.

Premier Path Wealth Partners first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.41M in Q1 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Premier Path Wealth Partners held 4,297 shares of Zimmer Biomet worth $370K as of Q2 2026.
  • Premier Path Wealth Partners sold 1,810 Zimmer Biomet shares in Q2 2026, an estimated $159K.
  • Zimmer Biomet made up 0.04% of Premier Path Wealth Partners's portfolio in Q2 2026, its #322 holding.
  • Premier Path Wealth Partners first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Premier Path Wealth Partners's Zimmer Biomet position peaked at $1.41M in Q1 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.